AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer.
J Exp Clin Cancer Res
; 42(1): 204, 2023 Aug 10.
Article
in En
| MEDLINE
| ID: mdl-37563661
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Androgen Receptor Antagonists
/
Prostatic Neoplasms, Castration-Resistant
/
Mitochondrial Precursor Protein Import Complex Proteins
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Exp Clin Cancer Res
Year:
2023
Type:
Article
Affiliation country:
China